New research study shows impact of delirium for people with Parkinson’s in hospital Date 21 March 2024
Parkinson’s UK funds nearly £450,000 for research exploring new ways to manage Parkinson’s symptoms Date 19 March 2024
Parkinson’s UK to co-fund a phase 3 stage clinical trial with Cure Parkinson’s Date 10 January 2023 Through the Parkinson’s Virtual Biotech, we’re investing £1.1m to co-fund a study looking at whether a cough medicine, ambroxol, has the potential to slow the progression of Parkinson’s.
More research needed to investigate iron in Parkinson’s Date 12 December 2022 Results from a clinical trial looking at reducing iron levels in the brain have shown no benefit for unmedicated people with Parkinson’s.
Parkinson’s community boosts recruitment to clinical studies Date 16 November 2022 Back in the summer, we called upon the Parkinson’s community to take part in 5 clinical trials that were at a potential risk of closing. Thanks to you, we had an incredible response and want to keep up the momentum of encouraging people to take part in research.
We’re partnering with Enterin to develop a potential new treatment for Parkinson’s dementia Date 13 October 2022 We’re investing £2m in Enterin’s phase 2 clinical trial of its drug ENT-01, a potential treatment for Parkinson’s dementia.
Ex-international rugby players have an increased risk of developing Parkinson’s Date 6 October 2022 A study following Scottish international rugby players shows they are more likely to develop neurodegenerative conditions compared to the general public.
Artificial intelligence to help identify Parkinson’s Date 23 September 2022 A project involving Parkinson’s UK, shows promise for using artificial intelligence to identify Parkinson’s in brains donated to our Brain Bank.
‘Smelling Parkinson’s’ research could make it quicker and easier to diagnose Parkinson’s Date 7 September 2022 Scientists at the University of Manchester have developed a test which could help diagnose Parkinson’s in 3 minutes using a simple skin swab.
Parkinson’s UK funding research into drug that could slow Parkinson’s progression Date 1 September 2022 The £2.9m phase 2 trial of a drug that could slow the progression of conditions like Parkinson's will be funded by the Parkinson's Virtual Biotech, our international drug discovery and development programme.
Disappointing results from trials of vaccines for Parkinson’s, but hope for the future Date 12 August 2022 2 clinical trials aiming to reduce the clumps of troublesome alpha-synuclein to protect brain cells have, so far, failed to show a clear benefit for people with Parkinson’s.
Celebrating neuroscience in spring 2023 Date 4 August 2022 We are partnering with the British Neuroscience Association (BNA) to plan and deliver the BNA International Festival of Neuroscience 2023.